Acomplia, generic name Rimonabant, the new anti-obesity drug of the future, is a multi-functional miracle - it can reduce weight and help people quite smoking. In addition, Acomplia increases the levels of good cholesterol (HDL) in the body, while reducing the triglycerides (bad cholesterol) and develops the body's aptitude to handle and assimilate blood sugar.
Acomplia functions by blocking a cellular receptor (CB-1) found in the brain and fat cells. This receptor is involved with making people experience pleasurable sensations, which lead to cravings. Acomplia blocks this receptor and decreases cravings, which helps to curb appetites and stop tobacco cravings. Acomplia is generally advised for a period of two years. Acomplia is capable of fighting nicotine addiction along with weight reduction.
Acomplia blocks receptors in the brain and fat cells of a substance called cannabinoid 1 that controls food consumption and tobacco addiction. Acomplia diet pills mechanism of selective targeting and blocking CB1 receptors makes it different from the conventional weight loss drugs. Acomplia actually decreases the over activity of cannabinoid thus making hunger and nicotine craving more manageable.
Acomplia has the potential to be the best weight loss product in the diet market. A huge portion of our population are struggling with obesity or smoking addiction or both and billions of dollars are spent on medical treatment of these addictions. Acomplia may be a life saving drug, that can help decrease the cravings for food and nicotine and give people the chance to change their habits, have a healthier life, and live longer.
|
